Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 93

1.

Recent patents and advances in genomic biomarker discovery for colorectal cancers.

Quyun C, Ye Z, Lin SC, Lin B.

Recent Pat DNA Gene Seq. 2010 Jun;4(2):86-93. Review.

PMID:
20426761
[PubMed - indexed for MEDLINE]
2.

Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening.

Ng EK, Chong WW, Jin H, Lam EK, Shin VY, Yu J, Poon TC, Ng SS, Sung JJ.

Gut. 2009 Oct;58(10):1375-81. doi: 10.1136/gut.2008.167817. Epub 2009 Feb 6.

PMID:
19201770
[PubMed - indexed for MEDLINE]
3.

Plasma miR-21: a potential diagnostic marker of colorectal cancer.

Kanaan Z, Rai SN, Eichenberger MR, Roberts H, Keskey B, Pan J, Galandiuk S.

Ann Surg. 2012 Sep;256(3):544-51. doi: 10.1097/SLA.0b013e318265bd6f.

PMID:
22868372
[PubMed - indexed for MEDLINE]
4.

Epigenetic biomarkers in colorectal cancer diagnostics.

Rawson JB, Bapat B.

Expert Rev Mol Diagn. 2012 Jun;12(5):499-509. doi: 10.1586/erm.12.39. Review.

PMID:
22702366
[PubMed - indexed for MEDLINE]
5.

Noninvasive molecular biomarkers for the detection of colorectal cancer.

Kim HJ, Yu MH, Kim H, Byun J, Lee C.

BMB Rep. 2008 Oct 31;41(10):685-92. Review.

PMID:
18959813
[PubMed - indexed for MEDLINE]
Free Article
6.

MicroRNA regulatory network in human colorectal cancer.

Tang JT, Fang JY.

Mini Rev Med Chem. 2009 Jul;9(8):921-6. Review.

PMID:
19601887
[PubMed - indexed for MEDLINE]
7.

DNA methylation markers in colorectal cancer.

Kim MS, Lee J, Sidransky D.

Cancer Metastasis Rev. 2010 Mar;29(1):181-206. doi: 10.1007/s10555-010-9207-6. Review.

PMID:
20135198
[PubMed - indexed for MEDLINE]
8.

Pathogenetic and clinical relevance of microRNAs in colorectal cancer.

Valeri N, Croce CM, Fabbri M.

Cancer Genomics Proteomics. 2009 Jul-Aug;6(4):195-204. Review.

PMID:
19656996
[PubMed - indexed for MEDLINE]
Free Article
9.

Epigenetic regulation of microRNA expression in colorectal cancer.

Bandres E, Agirre X, Bitarte N, Ramirez N, Zarate R, Roman-Gomez J, Prosper F, Garcia-Foncillas J.

Int J Cancer. 2009 Dec 1;125(11):2737-43. doi: 10.1002/ijc.24638.

PMID:
19521961
[PubMed - indexed for MEDLINE]
10.

miRNAs as biomarkers in colorectal cancer diagnosis and prognosis.

Ju J.

Bioanalysis. 2010 May;2(5):901-6. doi: 10.4155/bio.10.45. Review.

PMID:
20543966
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Novel blood-based, five-gene biomarker set for the detection of colorectal cancer.

Han M, Liew CT, Zhang HW, Chao S, Zheng R, Yip KT, Song ZY, Li HM, Geng XP, Zhu LX, Lin JJ, Marshall KW, Liew CC.

Clin Cancer Res. 2008 Jan 15;14(2):455-60. doi: 10.1158/1078-0432.CCR-07-1801. Epub 2008 Jan 18.

PMID:
18203981
[PubMed - indexed for MEDLINE]
Free Article
12.

Predictive molecular classifiers in colorectal cancer.

Bohanes P, LaBonte MJ, Winder T, Lenz HJ.

Semin Oncol. 2011 Aug;38(4):576-87. doi: 10.1053/j.seminoncol.2011.05.012. Review.

PMID:
21810517
[PubMed - indexed for MEDLINE]
13.

MicroRNAs in colorectal cancer: translation of molecular biology into clinical application.

Slaby O, Svoboda M, Michalek J, Vyzula R.

Mol Cancer. 2009 Nov 14;8:102. doi: 10.1186/1476-4598-8-102. Review.

PMID:
19912656
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

DNA methylation biomarkers as diagnostic and prognostic tools in colorectal cancer.

Gyparaki MT, Basdra EK, Papavassiliou AG.

J Mol Med (Berl). 2013 Nov;91(11):1249-56. doi: 10.1007/s00109-013-1088-z. Epub 2013 Sep 21. Review.

PMID:
24057814
[PubMed - indexed for MEDLINE]
15.

Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer.

Arndt GM, Dossey L, Cullen LM, Lai A, Druker R, Eisbacher M, Zhang C, Tran N, Fan H, Retzlaff K, Bittner A, Raponi M.

BMC Cancer. 2009 Oct 20;9:374. doi: 10.1186/1471-2407-9-374.

PMID:
19843336
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

MicroRNA signatures: novel biomarker for colorectal cancer?

Luo X, Burwinkel B, Tao S, Brenner H.

Cancer Epidemiol Biomarkers Prev. 2011 Jul;20(7):1272-86. doi: 10.1158/1055-9965.EPI-11-0035. Epub 2011 May 6. Review.

PMID:
21551242
[PubMed - indexed for MEDLINE]
Free Article
17.

Role of genomic markers in colorectal cancer treatment.

Allen WL, Johnston PG.

J Clin Oncol. 2005 Jul 10;23(20):4545-52. Review.

PMID:
16002846
[PubMed - indexed for MEDLINE]
Free Article
18.

Performance of epigenetic markers SEPT9 and ALX4 in plasma for detection of colorectal precancerous lesions.

Tänzer M, Balluff B, Distler J, Hale K, Leodolter A, Röcken C, Molnar B, Schmid R, Lofton-Day C, Schuster T, Ebert MP.

PLoS One. 2010 Feb 4;5(2):e9061. doi: 10.1371/journal.pone.0009061.

PMID:
20140221
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Frequency and type of KRAS mutations in routine diagnostic analysis of metastatic colorectal cancer.

Neumann J, Zeindl-Eberhart E, Kirchner T, Jung A.

Pathol Res Pract. 2009;205(12):858-62. doi: 10.1016/j.prp.2009.07.010. Epub 2009 Aug 12.

PMID:
19679400
[PubMed - indexed for MEDLINE]
20.

Common and distinct genomic events in sporadic colorectal cancer and diverse cancer types.

Martin ES, Tonon G, Sinha R, Xiao Y, Feng B, Kimmelman AC, Protopopov A, Ivanova E, Brennan C, Montgomery K, Kucherlapati R, Bailey G, Redston M, Chin L, DePinho RA.

Cancer Res. 2007 Nov 15;67(22):10736-43.

PMID:
18006816
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk